Cargando…

Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)

BACKGROUND: Exercise is an effective adjuvant therapy that can alleviate treatment-related toxicities for men with prostate cancer (PC). However, the feasibility of delivering exercise training to men with advanced disease and the wider impact on clinical outcomes remain unknown. The purpose of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Malcolm, Murphy, Marie H., McAneney, Helen, McBride, Ken, Crawford, Ffiona, Cole, Aidan, O’Sullivan, Joe M., Jain, Suneil, Prue, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319656/
https://www.ncbi.nlm.nih.gov/pubmed/37402060
http://dx.doi.org/10.1007/s00520-023-07894-1
_version_ 1785068284844965888
author Brown, Malcolm
Murphy, Marie H.
McAneney, Helen
McBride, Ken
Crawford, Ffiona
Cole, Aidan
O’Sullivan, Joe M.
Jain, Suneil
Prue, Gillian
author_facet Brown, Malcolm
Murphy, Marie H.
McAneney, Helen
McBride, Ken
Crawford, Ffiona
Cole, Aidan
O’Sullivan, Joe M.
Jain, Suneil
Prue, Gillian
author_sort Brown, Malcolm
collection PubMed
description BACKGROUND: Exercise is an effective adjuvant therapy that can alleviate treatment-related toxicities for men with prostate cancer (PC). However, the feasibility of delivering exercise training to men with advanced disease and the wider impact on clinical outcomes remain unknown. The purpose of the EXACT trial was to determine the feasibility and effects of home-based exercise training in men with metastatic castrate-resistant prostate cancer (mCRPC). METHODS: Patients with mCRPC receiving ADT + an androgen receptor pathway inhibitor (ARPI) were prescribed 12 weeks of home-based, remotely monitored, moderate intensity, aerobic and resistance exercise. Feasibility was assessed using recruitment, retention and adherence rates. Safety and adverse events were monitored throughout, with functional and patient-reported outcomes captured at baseline, post-intervention and at 3-month follow-up. RESULTS: From the 117 screened, 49 were deemed eligible and approached, with 30 patients providing informed consent (61% recruitment rate). Of those who consented, 28 patients completed baseline assessments, with 24 patients completing the intervention and 22 completing follow-up (retention rates: 86% and 79% respectively). Task completion was excellent throughout, with no intervention-related adverse events recorded. Self-reported adherence to the overall intervention was 82%. Exercise training decreased mean body mass (−1.5%), improved functional fitness (> 10%) and improved several patient-reported outcomes including clinically meaningful changes in fatigue (p = 0.042), FACT-G (p = 0.054) and FACT-P (p = 0.083), all with moderate effect sizes. CONCLUSION: Home-based exercise training, with weekly remote monitoring, was feasible and safe for men with mCRPC being treated with an ARPI. Given that treatment-related toxicities accumulate throughout the course of treatment, and as a result, negatively impact functional fitness and health-related quality of life (HRQoL), it was positive that exercise training improved or prevented a decline in these clinically important variables and could better equip patients for future treatment. Collectively, these preliminary feasibility findings support the need for a definitive, larger RCT, which downstream may lead to the inclusion of home-based exercise training as part of adjuvant care for mCRPC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-023-07894-1.
format Online
Article
Text
id pubmed-10319656
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-103196562023-07-06 Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT) Brown, Malcolm Murphy, Marie H. McAneney, Helen McBride, Ken Crawford, Ffiona Cole, Aidan O’Sullivan, Joe M. Jain, Suneil Prue, Gillian Support Care Cancer Research BACKGROUND: Exercise is an effective adjuvant therapy that can alleviate treatment-related toxicities for men with prostate cancer (PC). However, the feasibility of delivering exercise training to men with advanced disease and the wider impact on clinical outcomes remain unknown. The purpose of the EXACT trial was to determine the feasibility and effects of home-based exercise training in men with metastatic castrate-resistant prostate cancer (mCRPC). METHODS: Patients with mCRPC receiving ADT + an androgen receptor pathway inhibitor (ARPI) were prescribed 12 weeks of home-based, remotely monitored, moderate intensity, aerobic and resistance exercise. Feasibility was assessed using recruitment, retention and adherence rates. Safety and adverse events were monitored throughout, with functional and patient-reported outcomes captured at baseline, post-intervention and at 3-month follow-up. RESULTS: From the 117 screened, 49 were deemed eligible and approached, with 30 patients providing informed consent (61% recruitment rate). Of those who consented, 28 patients completed baseline assessments, with 24 patients completing the intervention and 22 completing follow-up (retention rates: 86% and 79% respectively). Task completion was excellent throughout, with no intervention-related adverse events recorded. Self-reported adherence to the overall intervention was 82%. Exercise training decreased mean body mass (−1.5%), improved functional fitness (> 10%) and improved several patient-reported outcomes including clinically meaningful changes in fatigue (p = 0.042), FACT-G (p = 0.054) and FACT-P (p = 0.083), all with moderate effect sizes. CONCLUSION: Home-based exercise training, with weekly remote monitoring, was feasible and safe for men with mCRPC being treated with an ARPI. Given that treatment-related toxicities accumulate throughout the course of treatment, and as a result, negatively impact functional fitness and health-related quality of life (HRQoL), it was positive that exercise training improved or prevented a decline in these clinically important variables and could better equip patients for future treatment. Collectively, these preliminary feasibility findings support the need for a definitive, larger RCT, which downstream may lead to the inclusion of home-based exercise training as part of adjuvant care for mCRPC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00520-023-07894-1. Springer Berlin Heidelberg 2023-07-04 2023 /pmc/articles/PMC10319656/ /pubmed/37402060 http://dx.doi.org/10.1007/s00520-023-07894-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Brown, Malcolm
Murphy, Marie H.
McAneney, Helen
McBride, Ken
Crawford, Ffiona
Cole, Aidan
O’Sullivan, Joe M.
Jain, Suneil
Prue, Gillian
Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
title Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
title_full Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
title_fullStr Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
title_full_unstemmed Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
title_short Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT)
title_sort feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (exact)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319656/
https://www.ncbi.nlm.nih.gov/pubmed/37402060
http://dx.doi.org/10.1007/s00520-023-07894-1
work_keys_str_mv AT brownmalcolm feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT murphymarieh feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT mcaneneyhelen feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT mcbrideken feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT crawfordffiona feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT coleaidan feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT osullivanjoem feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT jainsuneil feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact
AT pruegillian feasibilityofhomebasedexercisetrainingduringadjuvanttreatmentformetastaticcastrateresistantprostatecancerpatientstreatedwithanandrogenreceptorpathwayinhibitorexact